Compare AIR & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AIR | CAI |
|---|---|---|
| Founded | 1951 | 2008 |
| Country | United States | United States |
| Employees | N/A | 1846 |
| Industry | Aerospace | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 5.0B |
| IPO Year | 1994 | N/A |
| Metric | AIR | CAI |
|---|---|---|
| Price | $135.67 | $16.99 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 11 |
| Target Price | ★ $131.20 | $30.91 |
| AVG Volume (30 Days) | 404.4K | ★ 2.8M |
| Earning Date | 03-24-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.59 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $18.83 | $25.24 |
| Revenue Next Year | $10.93 | $22.32 |
| P/E Ratio | $38.04 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $71.43 | $14.19 |
| 52 Week High | $146.75 | $42.50 |
| Indicator | AIR | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 57.73 | 46.60 |
| Support Level | $101.48 | $17.15 |
| Resistance Level | $146.75 | $19.83 |
| Average True Range (ATR) | 5.68 | 1.24 |
| MACD | -0.99 | -0.12 |
| Stochastic Oscillator | 49.39 | 14.97 |
AAR Corp is engaged in providing products and services to aviation, government and defense market. It operates in segments namely: The parts supply segment majorly consists of sales and leasing of USM and aftermarket distribution of new, OEM-supplied replacement parts; Repair & Engineering segment provides airframe maintenance, component repair, and landing gear overhaul services; Integrated Solutions segment consists of its fleet management and operations of customer-owned aircraft, customized performance-based supply chain logistics programs in support of the U.S. Department of Defense, flight hour component inventory; and The Expeditionary Services segment consists of products and services supporting the movement of equipment and personnel by the U.S. and foreign governments and NGOs.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.